Thomas Weitao Sun

USPTO Granted Patents = 29 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 358(Granted Patents)

Location History:

Fremont, CA (US) (2001 - 2013)
Palo Alto, CA (US) (2009 - 2022)

Company Filing History:

24 out of 488

Rigel Pharmaceuticals, Incorporated

Years Active: 2001-2022

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE48898 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2022-01-24),

2. 10577381 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2020-03-03),

3. 10357505 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2019-07-23),

4. RE47034 - Topical formulation for administering a compound (2018-09-10),

5. 9737554 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2017-08-22),

6. 9532998 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2017-01-03),

7. 9283238 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2016-03-15),

8. 9266912 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2016-02-23),

9. 9040061 - Topical formulation for administering a compound (2015-05-26),

10. 8912170 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2014-12-16),

11. 8785437 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2014-07-22),

12. 8652492 - Wet granulation using a water sequestering agent (2014-02-18),

13. 8476263 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2013-07-02),

14. 8445485 - Prodrugs of 2,4-pyrimidinediamine compounds and their uses (2013-05-21),

15. 8372415 - Wet granulation using a water sequestering agent (2013-02-12),

Title: Innovations by Thomas Weitao Sun: Significant Contributions to Pharmaceutical Chemistry

Introduction

Thomas Weitao Sun, an accomplished inventor based in Fremont, CA, has made remarkable strides in the field of pharmaceutical chemistry. With a total of 29 patents to his name, his contributions are vital to advancing medicinal compounds and their therapeutic applications.

Latest Patents

Among his latest achievements, Sun has developed prodrugs of biologically active 2,4-pyrimidinediamine compounds. These prodrugs come with an array of benefits, as they include compositions comprising the prodrugs, salts, and hydrates, along with detailed methods for synthesizing these compounds. His work provides valuable insights into various applications of these medicinal compounds, highlighting their significance in modern pharmaceutical practices.

Career Highlights

Throughout his career, Thomas Weitao Sun has worked for prominent companies, including Rigel Pharmaceuticals, Incorporated, and Syntex (U.S.A.) Inc. His tenure in these organizations has substantially impacted the research and development of innovative drug solutions, solidifying his reputation in the industry.

Collaborations

Sun's innovation journey has been complemented by collaborations with skilled professionals, such as Rajinder Paul Singh and Somasekhar Bhamidipati. These partnerships have contributed to the growth and evolution of his groundbreaking inventions, further enhancing the potential of his pharmaceutical contributions.

Conclusion

Thomas Weitao Sun's impressive portfolio of patents and his dedicated career in pharmaceutical research underline his role as a significant innovator in the industry. His ongoing work with 2,4-pyrimidinediamine compounds exemplifies how his inventions can shape the future of medicine and provide solutions for various therapeutic needs.

This text is generated by artificial intelligence and may not be accurate.